By Amanda Ernst ( June 13, 2007, 12:00 AM EDT) -- KV Pharmaceutical Co. on Tuesday filed an answer and counterclaims to Purdue Pharma LP's allegations of infringement of three patents for controlled-release oxycodone, claiming that the patents-in-suit are unenforceable because Purdue fraudulently acquired them and used them as part of an anti-competitive scheme....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.